Stay updated on SENSITIZE: 4SC-202 + Pembrolizumab Clinical Trial
Sign up to get notified when there's something new on the SENSITIZE: 4SC-202 + Pembrolizumab Clinical Trial page.

Latest updates to the SENSITIZE: 4SC-202 + Pembrolizumab Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoNo Change Detected
- Check17 days agoChange DetectedThe page shows a minor version update from Revision: v3.3.1 to Revision: v3.3.2 in the footer. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check24 days agoChange DetectedRevision: v3.3.1 is displayed as a page revision update (replacing v3.2.0) in the header/footer area with no changes to study data or navigation. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check31 days agoChange DetectedThe page removed a government funding and operating status notice. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check45 days agoChange DetectedMinor layout and formatting updates are visible; core study details such as title, criteria, design, and outcomes appear unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check74 days agoChange DetectedAdded a government funding notice and an updated software version (v3.2.0), removing the old v3.1.0; this primarily updates the page’s operating status guidance and versioning.SummaryDifference5%

- Check81 days agoChange DetectedUpdated version from v3.0.2 to v3.1.0, with the addition of the new revision tag and removal of the old one.SummaryDifference0.3%

Stay in the know with updates to SENSITIZE: 4SC-202 + Pembrolizumab Clinical Trial
Enter your email address, and we'll notify you when there's something new on the SENSITIZE: 4SC-202 + Pembrolizumab Clinical Trial page.